Abstract Trisomies 18 and 21 are the two most common live born autosomal aneuploidies in humans. While the anatomic abnormalities in affected fetuses are well documented, the dysregulated biological pathways associated with the development of the aneuploid phenotype are less clear. Amniotic fluid (AF) cell-free RNA is a valuable source of biological information obtainable from live fetuses. In this study, we mined gene expression data previously produced by our group from mid-trimester AF supernatant samples. We identified the euploid, trisomy 18 and trisomy 21 AF transcriptomes, and analyzed them with a particular focus on the nervous system. We used multiple bioinformatics resources, including DAVID, Ingenuity Pathway Analysis, and the BioGPS Gene Expression Atlas. Our analyses confirmed that AF supernatant from aneuploid fetuses is enriched for nervous system gene expression and neurological disease pathways. Tissue analysis showed that fetal brain cortex and Cajal-Retzius cells were significantly enriched for genes contained in the AF transcriptomes. We also examined AF transcripts known to be dysregulated in aneuploid fetuses compared with euploid controls and identified several brain-specific transcripts among them. Many of these genes play critical roles in nervous system development. NEUROD2, which was downregulated in trisomy 18, induces neurogenic differentiation. SOX11, downregulated in trisomy 21, is a transcription factor that is essential for pan-neuronal protein expression and axonal growth of sensory neurons. Our results show that whole transcriptome analysis of cell-free RNA in AF from live pregnancies permits discovery of biomarkers of abnormal human neurodevelopment and advances our understanding of the pathophysiology of aneuploidy.
Introduction
Trisomies 18 and 21 are the two most common live born autosomal aneuploidies in humans. While the anatomic abnormalities in affected fetuses have been well documented with prenatal sonography (Bianchi et al. 2010) , the dysregulated biological pathways associated with the aneuploid phenotypes are less clear. To study human fetal development, gene expression studies have largely relied on post-partum or post-mortem tissue samples. Samples from live fetuses have almost exclusively been performed using cultured amniocytes or chorionic villi (Altug-Teber et al. 2007; Chung et al. 2005; Chou et al. 2008) . These sample sources are all inherently limited in their ability to reflect in vivo physiology. Mid-trimester amniotic fluid (AF) is valuable because it is a pure fetal biofluid that reflects ongoing in utero physiology. The residual cell-free RNA that is present after amniocytes have been removed for clinical diagnosis is an excellent source of biological information (Hui and Bianchi 2011) . Prior studies from our group have shown that cell-free RNA from AF can be successfully isolated and used for global gene expression studies of abnormal pregnancies (Larrabee et al. 2005; Slonim et al. 2009; Koide et al. 2011) .
In recent work, we analyzed the AF transcriptome in euploid fetuses by mining gene expression data from 12 mid-trimester AF supernatants (Hui et al. 2012) . Our results suggested that the cell-free RNA in AF derives from multiple tissues. More specifically, functional analysis indicated that nervous system development and function is enriched in the euploid AF transcriptome. Despite our lack of knowledge about their precise route of entry and their in vivo half-life, brain-derived transcripts may be a novel source of biomarkers of nervous system development that are uniquely accessible from living fetuses. These findings prompted us to establish whether AF supernatant could be a useful tool for studying fetal neurodevelopment in aneuploid pregnancies.
In this study, we mined gene expression data previously produced by our group from aneuploid AF supernatant samples (Koide et al. 2011; Slonim et al. 2009 ), focusing on the transcripts associated with nervous system development. We newly created the trisomy 18 and 21 transcriptomes, which consist of the universally detected transcripts in AF from mid-trimester trisomy 18 and trisomy 21 fetuses, respectively. Our aims were to determine if nervous system gene expression is enriched in AF supernatant from aneuploid fetuses, and to identify differentially regulated nervous system-specific transcripts in AF that may represent potential biomarkers of abnormal neurodevelopment.
Materials and methods
The euploid, trisomy 21 and trisomy 18 transcriptomes We newly analyzed gene expression datasets from midtrimester euploid and aneuploid AF samples produced in prior microarray studies from our group. These data are publicly available at http://www.ncbi.nlm.nih.gov/geo/ (GSE25634, GSE16176, and GSE33168). Institutional review board approval was obtained for the initial collection and analysis of all samples. The methods of sample collection, RNA extraction, fragmentation, labeling, and hybridization have been previously described (Slonim et al. 2009 ). In brief, RNA was extracted from 10 ml of AF supernatant from women undergoing fetal testing for clinical indications. The trisomy 21 transcriptome was derived from five male and two female fetuses with trisomy 21 (16-21 weeks), the trisomy 18 transcriptome from five female fetuses with trisomy 18 (17-20 weeks) and the euploid transcriptome from six male and six female euploid fetuses (16-21 weeks). There was no pooling of samples. The final amplified cDNA products were hybridized to Affymetrix U133 Plus 2.0 microarrays (Affymetrix, Santa Clara, CA). Each AF sample was anonymized before being received in the research laboratory. Only gestational age and karyotype were available. No data were available for the presence of structural anomalies at the time of amniocentesis.
Data were normalized using the threestep function from the affyPLM package in Bioconductor (version 2.8.1) (Gentleman et al. 2004) , with ideal-mismatch background/ signal adjustment, quantile normalization, and the Tukey biweight summary method ). This summary method includes a logarithmic transformation that improves the normality of the data. To obtain detection calls consistent with those produced by Affymetrix Ò 5.0 software, we used the mas5calls function from the Bioconductor affy package.
We identified the euploid, trisomy 18 and 21 transcriptomes by selecting those transcripts present in 100 % of euploid, trisomy 18 and trisomy 21 AF supernatant samples, respectively. The enrichment of specific tissue expression was explored using multiple tools. See Table 1 for summary of study methods. . DAVID also calculates a more conservative P value using the Benjamini-Hochberg correction to control the false discovery rate of family-wise enriched terms. We defined results as significant if the tissue term had a Benjamini-Hochberg corrected P value \0.05. We uploaded the euploid, trisomy 21 and trisomy 18 transcriptome gene lists to DAVID. We reported the top ranked tissues for each database and karyotype, as well as the individual neurological tissues that met statistical significance.
Identification of tissue-specific genes in the aneuploid transcriptomes
The BioGPS Gene Expression Atlas at http://biogps.org identified genes with tissue-specific expression patterns in the trisomy 21 and 18 transcriptomes. This atlas of the human protein-encoding transcriptome used Affymetrix Human Genome-U133A and custom human arrays to map gene expression profiles in 78 normal human tissues (Su et al. 2004 ). We chose this resource because of its Affymetrix microarray platform, coverage of normal adult and fetal tissues, high reproducibility and good correlation between transcript levels and protein abundance (Kislinger et al. 2006) . The BioGPS Gene Expression Atlas allowed us to assess the gene expression patterns of individual Affymetrix probe sets in the trisomy 18 and 21 transcriptomes. We categorized probe sets as highly organ specific if they mapped to a single organ with an expression value [30 multiples of the median (MoM) and had no unrelated tissue expression greater than one-third of the maximum expression level.
Functional analyses of the trisomy 18 and 21 transcriptomes
The web-based software tool Ingenuity Pathway Analysis Version 9.0 (IPA) (Content Version 11904312) was used for the biological interpretation of the trisomy 18 and trisomy 21 AF transcriptome gene lists (Ingenuity Systems, Redwood City, CA, USA; http://www.ingenuity.com). Functional analysis of the euploid transcriptome has been previously reported by our group and was not repeated here (Hui et al. 2012) . IPA uses a manually curated repository of biological interactions and functional annotations to identify the most statistically significant signaling pathways and biological processes represented in a given gene set. The right-tailed Fisher's exact test is used by IPA to calculate a P value representing the probability that a biological function not really relevant to the AF transcriptome is reported as relevant. Controlling for multiple pathway testing is performed with the Benjamini-Hochberg correction. Diseases and disorder pathways that contained at least one functional annotation with a Benjamini-Hochberg corrected P value \0.05 were considered statistically significant.
Identification of differentially regulated tissue-specific genes in aneuploid fetuses
Genes that were significantly differentially expressed in trisomies 18 or 21 AF supernatants compared with euploid controls matched for gestational age and fetal sex were obtained from prior published work from our group (Slonim et al. 2009; Koide et al. 2011) . We used the BioGPS Gene Expression Atlas to identify the differentially regulated genes that were specifically expressed by the nervous system according to the method described above for the aneuploid transcriptomes.
Results
In the trisomy 21 dataset, 1,644 probe sets received a present call in all seven samples, corresponding to 1,184 individual genes in the transcriptome (Supplemental Table 1 ). In the trisomy 18 dataset, 1,076 probe sets were present in all five samples, corresponding to 746 genes (Supplemental Table 2 ). The euploid dataset contained 806 probe sets that were present in all 12 samples, corresponding to 536 genes. Nervous system gene expression was consistently represented in our analyses of these datasets.
Comparison of the trisomy 21 AF transcriptome to the Down syndrome gene expression meta analysis
Results from the statistical meta analysis of 45 heterogeneous trisomy 21 data sets were compared to the trisomy 21 AF transcriptome (Vilardell et al. 2011) . Fifty of 324 (15.4 %) genes identified in the meta analysis were present in trisomy 21 AF transcriptome, including genes physically located on chromosome 21 (APP, SOD1, DYRK1A, and RCAN1) (Supplemental Table 3 ). In contrast, only 17 (5.2 %) of the meta analysis genes were universally detectable in the euploid AF samples. Analysis of KEGG pathways in the trisomy 21 AF transcriptome using the functional annotation tool in DAVID showed one statistically significant functional cluster (Enrichment score [1.3 ). This single cluster contained three of the four neuropathological KEGG pathways present in the meta analysis gene list (Table 2) .
Tissue expression analyses
The DAVID tissue expression analysis showed that transcripts from multiple organs are enriched in AF, including the fetal nervous system, embryonic stem cells, pooled cell lines, umbilical cord, and epithelia (Table 3) . Fetal brain cortex and Cajal-Retzius cells consistently ranked in the top four tissues in the UniProt database (Table 4) . A Unigene expressed sequence tag library derived primarily from fetal cochlea was also highly ranked. Many other nervous system tissues met statistical significance across all DAVID databases, including adult caudate nucleus, whole brain, whole fetal brain, spinal cord, retina and many neurological malignancies (Supplemental Table 4 ). * Benjamini-Hochberg corrected P value a Group Enrichment Score is the geometric mean (in -log scale) of member's P values in a corresponding annotation cluster, and is used to rank their biological significance Tissue-specific genes in the aneuploid transcriptomes
The search for tissue-specific genes using the Gene Expression Atlas at BioGPS identified genes in the trisomy 21 and 18 AF transcriptomes that were specifically expressed by the nervous system. A total of 61 organspecific genes were identified in the trisomy 21 AF transcriptome gene list. The most highly represented tissues were hematopoetic/immune cells (19 genes), epithelial cells from skin, oral cavity and respiratory tract (14 genes) and nervous system (12 genes). These results are consistent with the tissues identified in the DAVID tissue expression analysis. The trisomy 18 transcriptome contained six nervous system-specific genes among the total of 36 tissuespecific genes. The complete lists of tissue-specific genes are available in Supplemental Tables 6 and 7 .
Functional analyses of trisomy 21 and trisomy 18 AF transcriptomes IPA identified neurological disease as the first and second most highly enriched disease pathway in the trisomy 21 and 18 datasets, respectively (Tables 5, 6 ). There was a considerable overlap of specific functional annotations within the neurological disease category between the two aneuploid groups (Supplemental Table 8 ). The infectious diseases annotations that were highly ranked in both groups related primarily to immune mechanisms against infection or cell surface proteins involved in the mechanisms of viral infection. We specifically excluded the biological category of cancer because cell proliferation functions that are normal in the developing human cause the IPA disease category ''cancer'' to be highly significant in fetal datasets (unpublished observations).
Identification of differentially regulated tissue-specific genes in aneuploid fetuses
There was significant differential regulation of several nervous system-specific genes in trisomy 21 and 18 fetuses, including transcription factors with critical roles in neuronal differentiation. These genes represent potential biomarkers of abnormal neurodevelopment (Table 7) . Of the 318 genes that were differentially regulated in trisomy 21 fetuses compared with matched euploid controls, 22 were tissue specific (Supplemental Table 9 ). Four genes of these genes were specifically expressed by the nervous system: SOX11 and DAAM2 were downregulated, and MEF2C and CELSR2 were upregulated in trisomy 21 fetuses, respectively. Of the 264 genes that were differentially regulated in trisomy 18 fetuses compared with matched euploid controls, there were 13 organ-specific genes (Supplemental Table 10 ). Three neurological tissue-specific genes were upregulated (PLEKHA4, PRPH2, and GPM6Z) and three were downregulated (NEUROD2, SOBP and PTPRD). There was no overlap between the trisomy 21 and trisomy 18 differentially regulated nervous system-specific genes.
Discussion
We applied multiple bioinformatic tools to explore the gene expression information contained in AF cell-free RNA from euploid, trisomy 21 and trisomy 18 fetuses. In this study, we focused on the neurodevelopmental data in the aneuploid groups because of the importance of developmental disability to the phenotypes of trisomy 21 and 18. We showed that the transcripts consistently present in AF are enriched for nervous system tissue expression and identified nervous-specific genes that are differentially regulated in aneuploid fetuses compared with euploid controls.
The significant result for the KEGG pathway for Alzheimer's disease in both the trisomy 21 AF transcriptome and the Down syndrome meta analysis is consistent with the known neuropathology of Down syndrome. This suggests that AF supernatant reflects real tissue biology and is therefore valid for studying human neurodevelopment. Of particular interest was the finding from the DAVID tissue expression analysis that Cajal-Retzius cells and fetal cortex had highly enriched expression of genes in the AF transcriptomes. Cajal-Retzius cells are reelin-producing neurons found in the marginal zone of the fetal brain that play an essential role in neuronal migration and cortical development ( Fig. 1 Cajal-Retzius cell in the developing human fetal cerebral cortex at 13 weeks' gestation). The fact that nervous system tissues were enriched in AF across multiple independent databases gives us greater confidence that these findings reflect actual fetal biology and are not the result of noise inherent in high throughput gene expression data.
The significant neurological disease annotations obtained in the IPA functional analysis of the aneuploid transcriptomes provided additional confirmation that nervous system pathophysiology can be reflected in AF. However, it is important to note that the functional annotation of diseases within IPA is largely based on adult studies. We do not propose that all the features of specific disorders such as Huntington's disease or Parkinson's disease occur in aneuploid fetuses. Rather, we believe that the significant results for these categories are a result of the fact that many of the genes involved in these adult diseases are essential for normal neurodevelopment and are dysregulated in aneuploid fetuses.
We identified brain-specific genes that were dysregulated in aneuploid fetuses compared with euploid controls. Many of these genes play critical roles in nervous system development, as summarized in Table 7 . NEUROD2, which was downregulated in trisomy 18, is most highly expressed in the marginal zone in week 19 of human gestation (Franklin et al. 2001 ) and induces neurogenic differentiation (Ravanpay et al. 2010; Mattar et al. 2008) . SOBP, also downregulated in Trisomy 18, is involved in development of the cochlea, and defects in this gene have been linked to developmental disability (Birk et al. 2010; Chen et al. 2008) . Both hearing and intellectual impairment are consistent features of the trisomy 18 phenotype. SOX11, downregulated in trisomy 21, is a transcription factor expressed in the embryonic central and peripheral nervous systems and is of critical importance for the establishment of pan-neuronal protein expression (Bergsland et al. 2006 ) and axonal growth of embryonic sensory neurons (Lin et al. 2011) . These findings, uniquely derived from live human fetuses, provide novel information about the altered neurodevelopmental gene expression in trisomies 18 and 21. There is still a general paucity of information on the biology of cell-free RNA in AF (Hui and Bianchi 2011) . The mechanisms by which fetal transcripts enter the AF are still unknown. It is possible that differential entry or degradation of cell-free transcripts could influence the results of our analysis. Furthermore, cell-free RNA is inherently more degraded and generally produces lower hybridization rates than cellular RNA. Fresh tissue would be an ideal source of gene expression information, but given the practical issues associated with human studies, AF provides an important window on fetal development.
Conclusions
Multiple independent bioinformatics analyses confirm that AF supernatant of aneuploid fetuses is enriched for nervous system gene expression and neurological disease pathways. We identified nervous system-specific transcription factors with key roles in brain development that are differentially regulated in aneuploid fetuses compared with euploid controls. Whole transcriptome analysis of cell-free RNA in AF from live pregnancies permits discovery of biomarkers of abnormal human neurodevelopment and advances understanding of the pathophysiology of human aneuploidy.
